Magnusson authored the Swedish chapter in the Chambers and Partners Pharmaceutical Advertising Global Practice Guide 2026.

Magnusson Sverige (Sweden) has once again authored the Swedish chapter in the Chambers and Partners Pharmaceutical Advertising Global Practice Guide 2026.

As the regulatory landscape continue to evolve, advertising medicinal products requires a careful balance between innovation and strict compliance.

The Pharmaceutical Advertising 2026 guide provides up-to-date legal commentary and key insights on advertising of medicinal products to the general public and healthcare professionals, transparency, inducement/anti-bribery, enforcement, enforcement trends, and advertising of veterinary medicines.

Magnusson’s team included Morvarid Dorkhan Nilsson, Wille Steinert and Daniel Wengelin.

You can access the Pharmaceutical Advertising Global Practice Guide for Sweden here: https://lnkd.in/ddGuVKTZ